Tech & Science
Subscribe To Newsweek
Print & Digital
3 Month Trial—Save 85% off cover
3 Month Trial—Save 45% off cover
See All Subscription Options
Subscribe To The Newsletter
Please enter a valid email
This Week's Edition
Sunlight Could Boost Immune Activity in the Skin
Exclusive: Malala Yousafzai on What Comes Next
View All Features
Change Your Edition
days remaining on your subscription
BlackBerry was in trouble—and then Fairfax Holdings stepped in.
The Money’s on Her
At the Fed, Summers is out. Is Yellen in?
Money Man With Moxie
Who can? Icahn. The septuagenarian investor has deep pockets and a pugnacious streak.
How a German coach revived American men’s soccer.
Pulling up Stakes
Dan Loeb turned Yahoo around—then turned himself a nice profit.
The Good Banker
Herbert Allison defied Wall Street stereotypes.
Gold Loses its Luster
Wall Street got hot for the precious metal, then everything dimmed.
China Settles for Less
Is the economic miracle over?
Happy Days are Here Again
The prophets of American economic decline revise their thinking.
It’s All Greek to Him
Five years ago, Chobani didn’t exist. Now it’s a billion-dollar business. How the son of a small-town shepherd made good.
Is Apple Too Clever by Half?
Maybe corporate America finally got too greedy for its own good.
CEOS pursue lower taxes and then—surprise!—the public gets mad.
Fast Times In The Corner Office
Impatient investors. Volatile markets. Why the speed of business is dooming CEOs.
The company may just show us everything wrong with American business.
The IMAX Solution
A ‘giant’ way to save movies.
An outraged hedge funder bites into Apple.
A Bangalore Baron
An Indian CEO sits atop a cutthroat world.
Facebook Grows Up
Click ‘like’ for Graph Search.
Esther Duflo is pioneering a new form of development economics. Daniel Gross reports.
Too Big to Jail?
Why the biggest banks are getting off easy.
Merry Christmas to Me!
There’s no shame in the epidemic of self-gifting.
Calling All Cabs
Uber and the new road rage.
A Canadian takes the helm at the Bank of England.
What really did in America’s favorite guilty pleasure.
The Contagion of Success
Why consumers are optimistic again.
Meet the New Boss
Showman, lawyer, quant, jock. Daniel Gross on Citigroup’s continuing parade of CEOs, who always seem to be fighting the last battle.
The Botox Economy
Why drugmaker Allergan is the perfect company.
Can his team do enough to save the euro?
R. Bradford Malt
Meet the man who knows all about Mitt Romney's taxes.
Bankruptcy for Billionaires
When Bain walks out on its debts, it’s business as usual.
The housing market is coming back, writes Dan Gross.
Europe’s Other Sick Man
Portugal takes its medicine and muddles through.